Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Aethlon Medical, Inc. (AEMD) had Consolidated Net Income/Loss of $-7.15M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-7.15M |
|
-- |
|
-- |
|
$7.29M |
|
$-7.29M |
|
$0.14M |
|
$-7.15M |
|
$-7.15M |
|
$-7.15M |
|
$-7.15M |
|
|
Consolidated Net Income/Loss |
$-7.15M |
$-7.15M |
|
$-7.29M |
|
$-6.97M |
|
0.67M |
|
0.67M |
|
$-10.61 |
|
$-10.61 |
|
| Balance Sheet Financials | |
$5.57M |
|
$0.36M |
|
$0.76M |
|
$6.33M |
|
$1.45M |
|
-- |
|
-- |
|
$1.45M |
|
$4.89M |
|
$4.89M |
|
$4.89M |
|
1.57M |
|
| Cash Flow Statement Financials | |
$-7.00M |
|
$-0.00M |
|
$6.52M |
|
$5.60M |
|
$5.13M |
|
$-0.47M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-146.36% |
|
-146.36% |
|
-112.92% |
|
-146.36% |
|
$3.11 |
|
$-10.39 |
|
$-10.38 |
|